top of page
News, Events and Updates
Search
Anavex Life Sciences to Participate in the Annual Needham Virtual Neuroscience Forum
Mar 9, 2022
Anavex Life Sciences Announces Change of Auditor to Grant Thornton LLP
Mar 4, 2022
Anavex Life Sciences to Present at the 11th Annual SVB Leerink Global Healthcare Conference
Feb 10, 2022
Anavex Life Sciences Provides Business Update & Reports Fiscal 2022 First Quarter Financial Results
Feb 9, 2022
Anavex Life Sciences Provides Supplemental Information on ANAVEX®2-73 AVATAR Phase 3 Trial
Feb 4, 2022
Anavex Life Sciences to Announce Fiscal 2022 First Quarter Financial Results on Wednesday, 2/9/2022
Feb 3, 2022
ANAVEX®2-73 (Blarcamesine) AVATAR Phase 3 Trial met Primary and Secondary Efficacy Endpoints
Feb 1, 2022
Anavex Life Sciences Reports Positive Results from Phase 1 Clinical Trial of ANAVEX®3-71
Jan 10, 2022
Anavex Life Sciences Promotes Dr. Kaufmann to CSO and Appoints Dr. Hammond as CMO
Jan 6, 2022
10
11
12
13
14
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
